Centene Corp is a leading healthcare enterprise that specializes in providing a range of services designed to enhance the quality, accessibility, and affordability of healthcare for individuals and families, particularly those in underserved communities. The company primarily operates within the managed care sector, offering government-sponsored healthcare programs such as Medicaid and Medicare, as well as health insurance marketplace offerings. Centene's commitment to addressing the diverse needs of its members is underscored by its focus on innovative care models, integrated services, and a dedication to improving health outcomes through personalized support and a deep understanding of local health systems. Read More
Shares of health coverage company Centene (NYSE:CNC)
fell 3.3% in the morning session after JPMorgan cut its price target on the managed care company to $30 from $48. This move by JPMorgan followed Centene's recent second-quarter earnings report, where the company posted a loss of $0.16 per share, missing analyst estimates. The poor results were largely attributed to a significant reduction in the company's net 2025 Marketplace risk adjustment revenue transfer estimate, an issue that first came to light when Centene withdrew its full-year guidance on July 1st. The company's performance prompted a series of downgrades from Wall Street, with firms like UBS, Wells Fargo, and Morgan Stanley also cutting their price targets, signaling widespread concern over the company's ability to restore its earnings trajectory.
If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648
July 28, 2025 — A wave of legal uncertainty has once again cast a shadow over Centene Corporation (NYSE:CNC), as shareholders grapple with the implications of a new class action lawsuit that alleges securities fraud and corporate misrepresentation. The development has sent ripples across the healthcare investment sector and raised
Centene Corporation (NYSE:CNC), a leading healthcare enterprise specializing in managed care services for government-sponsored health programs, has transformed itself over the past four decades from a small regional player into a national powerhouse. Headquartered in St. Louis, Missouri, Centene's rise has been defined by an aggressive acquisition strategy, targeted
Centene Corporation (NYSE:CNC), one of the largest managed healthcare providers in the United States, faced a severe market backlash this week as news of a federal securities fraud investigation rocked the company and its investors. Shares of Centene plunged sharply amid growing concerns over the scope and implications of
Shares of health coverage company Centene (NYSE:CNC)
fell 3% in the morning session after the company was downgraded by Cantor Fitzgerald, which also lowered its price target on the stock. The downgrade from Cantor Fitzgerald analyst Sarah James added to a period of negative sentiment surrounding the health insurer. The negative outlook stemmed from Centene's recent withdrawal of its 2025 financial guidance. The company pulled its forecast after an independent report revealed that its Affordable Care Act (ACA) marketplace plans had slower-than-expected membership growth and higher-than-anticipated morbidity, which is the rate of disease or illness. This resulted in a significant $1.8 billion downward revision in expected revenue.
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation (“Centene” or the “Company”)(NYSE: CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
NEW YORK - July 28, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Centene Corporation (NYSE: CNC) of a class action securities lawsuit.
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the securities of Centene Corporation (“Centene” or the “Company”) (NYSE: CNC) between December 12, 2024 and June 30, 2025, inclusive.
Shares of health coverage company Centene (NYSE:CNC)
jumped 5.9% in the afternoon session after the company reported second-quarter results that missed earnings estimates, but the stock rallied as investors looked past the disappointment as sales came in ahead of expectations.
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.
Wall Street looked set to close the week on a high note, with large-cap benchmarks pushing higher in Friday's midday trading as optimism over corporate earnings and progress on global trade talks provided support for risk assets.
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Centene To Contact Him Directly To Discuss Their Options
NEW YORK - July 25, 2025 ( NEWMEDIAWIRE ) - Levi & Korsinsky, LLP notifies investors in Centene Corporation (NYSE: CNC) of a class action securities lawsuit.
